Literature DB >> 20083852

Overexpression of the fragile histidine triad (FHIT) gene in inflammatory bowel disease.

P M Wierzbicki1, K Adrych, D Kartanowicz, J Wypych, M Stanislawowski, M Zwolinska-Wcislo, K Celinski, D Skrodzka, J Godlewski, B Korybalski, M Smoczynski, Z Kmiec.   

Abstract

OBJECTIVE: FHIT gene encodes human diadenosine triphosphate hydrolase involved in the regulation of cell cycle and nucleotide metabolism and is a candidate tumor suppressor gene. AIM: To investigate expression of FHIT gene at the mRNA and protein levels in sporadic inflammatory bowel disease (IBD).
MATERIALS AND METHODS: FHIT mRNA was quantified by the validated real-time PCR (QPCR) and FHIT protein was detected by immunohistochemistry (IHC) in mucosal biopsies of 139 ulcerative colitis (UC), 19 Crohn's disease (CD) and 37 control patients.
RESULTS: Significant FHIT gene overexpression was found in 78% of active UC but not in CD. IHC showed comparable results to QPCR.
CONCLUSION: The local up-regulation of FHIT gene and protein expression in active UC may represent an adequate response against inflammatory challenge of epithelial cell homeostasis and protect against DNA damage and cell cycle disturbances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083852

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  3 in total

1.  Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.

Authors:  Piotr M Wierzbicki; Krystian Adrych; Dorota Kartanowicz; Marcin Stanislawowski; Anna Kowalczyk; Janusz Godlewski; Iwona Skwierz-Bogdanska; Krzysztof Celinski; Tomasz Gach; Jan Kulig; Bartlomiej Korybalski; Zbigniew Kmiec
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

2.  Sequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes.

Authors:  Kristopher J Irizarry; Sukhaswami B Malladi; Xiangming Gao; Katherine Mitsouras; Lynda Melendez; Patricia A Burris; Jeffrey A Brockman; Samer W Al-Murrani
Journal:  BMC Genomics       Date:  2012-01-18       Impact factor: 3.969

3.  The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.

Authors:  Anna Liberek; Zbigniew Kmieć; Dorota Kartanowicz; Piotr M Wierzbicki; Marcin Stanisławowski; Lucyna Kaszubowska; Grażyna Luczak; Magdalena Góra-Gębka; Piotr Landowski; Agnieszka Szlagatys-Sidorkiewicz; Tomasz Liberek; Barbara Kamińska; Joanna Jakóbkiewicz-Banecka; Grzegorz Węgrzyn
Journal:  Int J Colorectal Dis       Date:  2012-05-15       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.